Aadel A. Chaudhuri, MD, PhD, on Personalizing Treatment for Oligometastatic Cancer

October 28, 2021 By The ASCO Post Staff

Aadel A. Chaudhuri, MD, PhD, of Washington University School of Medicine in St. Louis, discusses circulating tumor DNA, which has the potential to better personalize treatment for patients with oligometastatic cancer and help clinicians determine whether to offer systemic therapy alone or curative-intent local consolidative therapy.

Related Content